Welcome to our dedicated page for RYAN SPECIALTY HOLDINGS SEC filings (Ticker: RYAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on RYAN SPECIALTY HOLDINGS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into RYAN SPECIALTY HOLDINGS's regulatory disclosures and financial reporting.
Ryan Specialty Holdings EVP & General Counsel Mark Stephen Katz made an open-market purchase of company stock. He bought 3,215 shares of Class A Common Stock on June 3, 2026 at a weighted average price of $31.0694 per share, increasing his direct holdings to 4,332 shares.
The shares were acquired in multiple trades within a price range from $31.0550 to $31.0694, reflecting personal share accumulation rather than option exercises or tax-related transactions.
RYAN SPECIALTY HOLDINGS, INC. director Henry S. Bienen reported several bona fide gift transfers of Class A Common Stock, rather than any open‑market sales or purchases. On May 28, 2026, he gifted 5,757 shares held directly, reducing his direct position in these shares to zero while the same number of shares were gifted to the Henry S. Bienen 1997 Trust dated November 10, 1997. On May 29, 2026, the trust made an additional gift of 2,700 shares, leaving 27,795 shares held indirectly in that trust. The filing also shows a separate indirect holding entry of 28,590 shares in the Leigh Buchanan Bienen 1997 Trust dated November 10, 1997. Footnotes state the shares gifted on May 28 were transferred to the Henry S. Bienen 1997 Trust and that the reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.
Ryan Specialty Holdings increased its share repurchase program, authorizing up to an additional $300 million of Class A common stock, bringing the total program size to $600 million. As of May 22, 2026, after second-quarter repurchases and the increase, $300 million of authorization remained available.
The company repurchased $260 million of Class A common stock in the second quarter, fully using its prior $300 million authorization before the increase. Repurchases may occur via open-market purchases, privately negotiated deals, Rule 10b5-1 trading plans, or accelerated share repurchases, and the program can be suspended or discontinued at any time.
Ryan Specialty Holdings, Inc. Schedule 13G/A amendment states that Capital World Investors reports beneficial ownership of 0 shares representing 0.0% of the 128,670,686 shares believed to be outstanding. The filing is signed by Jae Won Chung on 05/13/2026.
Ryan Specialty Holdings, Inc. ownership disclosure by Vulcan Value Partners, LLC. Vulcan reports beneficial ownership of 6,595,335 shares of common stock, representing 5.12% of the class. The filing states Vulcan exercises sole dispositive power over all 6,595,335 shares and sole voting power over 4,317,624 shares.
The statement clarifies the shares are owned by Vulcan's investment advisory clients and not directly by Vulcan; Mr. C.T. Fitzpatrick is included as a potential control person but disclaims beneficial ownership and notes he and family own 271,744 shares in a managed account over which Vulcan serves as adviser.
Ryan Specialty Holdings, Inc. director and Chief Executive Officer Timothy William Turner received a grant of 168,577 Executive Chairman stock options. The options have an exercise price of $29.66 per share, expire on May 5, 2036, and are exercisable on a 1-for-1 basis into Class A common stock. They vest in equal installments on July 1, 2029, July 1, 2030, and July 1, 2031, and were approved by the board’s compensation and governance committee.
RYAN SPECIALTY HOLDINGS, INC. Co-President and CRO Brendan Martin Mulshine received a grant of 33,715 Executive Chairman stock options linked to Class A common stock. The options have a $29.66 per-share exercise price and expire on May 5, 2036.
These options vest in three equal installments on July 1, 2029, 2030 and 2031, and are exercisable on a 1-for-1 basis for Class A common shares. Following this grant, Mulshine holds 33,715 derivative securities directly. The grant was approved by the issuer’s compensation and governance committee for purposes of Rule 16(b)(3).
KATZ MARK STEPHEN reported acquisition or exercise transactions in this Form 4 filing.
Ryan Specialty Holdings reported that EVP & General Counsel Mark Stephen Katz received a grant of 33,715 Executive Chairman stock options on May 5, 2026. The options have a strike price of $29.66, vest in three equal parts on July 1 of 2029, 2030 and 2031, and expire on May 5, 2036. Following this award, he holds 33,715 options, each exercisable into one share of Class A common stock.
RYAN Specialty Holdings CEO Benjamin Miles Wuller received a grant of 33,715 Executive Chairman stock options as equity compensation. The options have an exercise price of $29.66 per share and are exercisable on a 1-for-1 basis into Class A common stock.
The options vest in equal installments on July 1 of 2029, 2030, and 2031 and expire on May 5, 2036. The grant was approved by the issuer’s compensation and governance committee for purposes of Rule 16(b)(3), and it is not an open-market share purchase.
RYAN SPECIALTY HOLDINGS, INC. reported that Chief Financial Officer Janice M. Hamilton received a grant of stock options tied to the company’s Class A common stock. The award covers 33,715 options with an exercise price of $29.66 per share and no cash changed hands at grant.
The options vest in three equal installments on July 1 of 2029, 2030 and 2031, and expire on May 5, 2036. Once vested, each option can be exercised on a 1-for-1 basis for one share of Class A common stock. This appears to be a routine compensation-related equity grant approved by the board’s compensation and governance committee.